Verenium Awarded U.S. Department of Energy Funding for Demonstration-Scale Facility
News Apr 23, 2010
Verenium Corporation has announced that it has been awarded an additional $4.9 million from the U.S. Department of Energy (DOE) to fund ongoing activities at its demonstration-scale facility in Jennings, Louisiana.
This cooperative agreement is an extension of the grant previously awarded to the Company in July of 2008 under a DOE program supporting the development of demonstration-scale cellulosic ethanol biorefinery plants.
"We are very pleased to receive this additional funding from the DOE, particularly given the critical work currently being performed at Jennings to optimize our cellulosic process," said Carlos A. Riva, President and Chief Executive Officer at Verenium. "I believe this award demonstrates further the DOE's support for our technology and commitment to developing a cellulosic ethanol supply industry."
The Company plans to use the additional funds to support on-going cellulosic technology and process optimization at its Jennings, LA demonstration facility.
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE
Scientists report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.